Literature DB >> 2578107

Effects of verapamil on exocrine pancreatic secretion in man.

C Niederau, A Hellmann, A Sonnenberg, J Erckenbrecht.   

Abstract

Calcium ions are thought to mediate hormonal and cholinergic stimulation of exocrine pancreatic secretion. In order to further eludicate the role of calcium ions in stimulus-secretion coupling of the pancreas, the effect of the calcium antagonist verapamil, which inhibits transmembrane calcium influx, was studied on pancreatic secretion in 35 healthy male volunteers. Every subject had two stimulation periods of 2 hr each with a 3-hr period between the two. Pancreatic secretion was stimulated by cholecystokinin in 12 subjects, by secretin in 14 subjects, and by sham feeding in 6 subjects. Three subjects were studied without any secretory stimulus. Verapamil as an intravenous bolus of 150 micrograms/kg followed by an intravenous infusion of 150 micrograms/kg/hr or saline were given during the two 2-hr stimulation periods in a randomized order. The pancreatic secretory responses to stimulation by cholecystokinin, secretin, or sham feeding, as well as the basal pancreatic secretion without a secretory stimulus were left unaffected by verapamil when compared to the saline control. The results, therefore, call into question the hypothesis that transmembrane calcium influx is a major mediator of pancreatic secretion in response to hormonal or cholinergic stimulation in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578107     DOI: 10.1007/bf01318374

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  [ON THE DETERMINATION OF TRYPSIN AND CHYMOTRYPSIN WITH AMINO-P-NITROANILIDES].

Authors:  W NAGEL; F WILLIG; W PESCHKE; F H SCHMIDT
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1965

2.  Analysis of the mechanism of action of calcium-induced exocrine pancreatic secretory changes in the dog.

Authors:  O Tiscornia; G Palasciano; J Dzieniszewski; H Verine; H Sarles
Journal:  Am J Gastroenterol       Date:  1975-04       Impact factor: 10.864

3.  Calcium antagonists and islet function--III. The possible site of action of verapamil.

Authors:  W J Malaisse; A Herchuelz; J Levy; A Sener
Journal:  Biochem Pharmacol       Date:  1977-04-15       Impact factor: 5.858

4.  Amylase release from dissociated mouse pancreatic acinar cells stimulated by glucagon: effect of membrane stabilizers.

Authors:  M Singh
Journal:  J Physiol       Date:  1980-12       Impact factor: 5.182

5.  Action pattern of human pancreatic alpha-amylase on maltoheptaose, a substrate for determining alpha-amylase in serum.

Authors:  E O Haegele; E Schaich; E Rauscher; P Lehmann; M Grassl
Journal:  J Chromatogr       Date:  1981-04-10

6.  Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and response.

Authors:  M Eichelbaum; M Albrecht; G Kliems; K Schäfer; A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

7.  Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.

Authors:  L De Marinis; A Barbarino
Journal:  Metabolism       Date:  1980-07       Impact factor: 8.694

8.  Calcium and stimulus-secretion coupling in gastric fundic mucosa. Effect of inhibition of calcium transport by verapamil on gastric acid secretion in the isolated guinea pig fundic mucosa and in healthy subjects.

Authors:  P Kirkegaard; J Christiansen; B Petersen; P Skov Olsen
Journal:  Scand J Gastroenterol       Date:  1982-06       Impact factor: 2.423

Review 9.  Regulation of pancreatic acinar cell function by intracellular calcium.

Authors:  J A Williams
Journal:  Am J Physiol       Date:  1980-04

10.  Pancreatic secretory response to sham feeding in humans.

Authors:  C Defilippi; T E Solomon; J E Valenzuela
Journal:  Digestion       Date:  1982       Impact factor: 3.216

View more
  1 in total

Review 1.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.